SL Therapeutics Company Description

SL Therapeutics, Inc. engages in cell therapy and medical device businesses.

The company develops cell therapeutic solutions based on its cell reprogramming technology to treat various diseases with a focus on spinal cord injury, and age and genetically related diseases; and hair follicle cells, skin cells, and cells of the central nervous system.

It also manufactures automated magnetic resonance imaging systems; and Supra Elite and Dexino bone mineral density measurement devices.

The company was formerly known as StemLab Inc. SL Therapeutics, Inc. was founded in 2011 and is headquartered in Seoul, South Korea.

SL Therapeutics, Inc.

Country	South Korea
Founded	2011
Industry	Commercial Physical and Biological Research
CEO	Jong Sung Choi

Contact Details

Address: 711, Techno Complex of Korea University Seoul, 02841 South Korea
Phone	82 2 2070 1177
Website	stemlab.co.kr

Stock Details

Ticker Symbol	258540
Exchange	Korea New Exchange
Reporting Currency	KRW
SIC Code	8731

Key Executives

Name	Position
Jong Sung Choi	Chief Executive Officer